Gene expression profiling of the human prostate zones

BJU International

Volumn 98, Issue 4, 2006, Pages 886-897

  Van Der Heul Nieuwenhuijsen, Leonie ^a   Hendriksen, Peter J M ^a   Van Der Kwast, Theo H ^b   Jenster, Guido ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Benign prostatic hyperplasia; Gene expression; Microarrays; Prostate cancer; Prostate zones

Indexed keywords

MARKER;

ARTICLE; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

FALSE POSITIVE REACTIONS; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748568153     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06427.x     Document Type: Article

References (30)

1. Shah US, Getzenberg RH. Fingerprinting the diseased prostate: associations between BPH and prostate cancer. J Cell Biochem 2004; 91: 161-9
2. Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology 1999; 53 (Suppl. 3): 1-6
3. Colombo P, Patriarca C, Alfano RM et al. Molecular disorders in transitional vs peripheral zone prostate adenocarcinoma. Int J Cancer 2001; 94: 383-9
4. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12: 897-906
5. De Marzo AM, Coffey DS, Nelson WG. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 1999; 53 (Suppl. 3): 29-42
6. Nelson PS. Predicting prostate cancer behavior using transcript profiles. J Urol 2004; 172: S28-33
7. McNeal JE. The zonal anatomy of the prostate. Prostate 1981; 2: 35-49
8. Laczkó I, Hudson DL, Freeman A, Feneley MR, Masters JR. Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics. Prostate 2005; 62: 260-6
9. Cunha GR, Hayward SW, Wang YZ, Ricke WA. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003; 107: 1-10
10. Cunha GR, Fujii H, Neubauer B, Shannon JM, Sawyer L, Reese BA. Epithelial-mesenchymal interactions in prostatic development. I. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 1983; 96: 1662-70
11. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 1990; 87: 1663-7
12. Chung LW, Hsieh CL, Law A et al. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. Urology 2003; 62 (Suppl. 5): 44-54
13. Singh D, Febbo PG, Ross K et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002; 1: 203-9
14. Dhanasekaran SM, Barrette TR, Ghosh D et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-6
15. Lapointe J, Li C, Higgins JP, van de Rijn M et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 2004; 101: 811-6
16. Stuart RO, Wachsman W, Berry CC et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci USA 2004; 101: 615-20
17. Stamey TA, Caldwell MC, Fan Z et al. Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue? J Urol 2003; 170: 2263-8
18. Wu X, Jin C, Wang F, Yu C, McKeehan WL. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Cancer Res 2003; 63: 4936-44
19. Li PX, Wong J, Ayed A et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000; 275: 20127-35
20. Liu T, Bauskin AR, Zaunders J et al. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003; 63: 5034-40
21. Welsh JB, Sapinoso LM, Su AI et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001; 61: 5974-8
22. Kakehi Y, Segawa T, Wu XX, Kulkarni P, Dhir R, Getzenberg RH. Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia. Prostate 2004; 59: 351-6
23. Maeda H, Nagata S, Wolfgang CD, Bratthauer GL, Bera TK, Pastan I. The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria. J Biol Chem 2004; 279: 24561-8
24. Wolfgang CD, Essand M, Lee B, Pastan I. T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin. Cancer Res 2001; 61: 8122-6
25. Bejsovec A. Wnt pathway activation: new relations and locations. Cell 2005; 120: 11-4
26. Wissmann C, Wild PJ, Kaiser S et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 2003; 201: 204-12
27. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS. Fox's in development and disease. Trends Genet 2003; 19: 339-44
28. Tran H, Brunet A, Grenier JM et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 2002; 296: 530-4
29. Alvarez B, Martinez AC, Burgering BM, Carrera AC. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 2001; 413: 744-7
30. Aitola M, Carlsson P, Mahlapuu M, Enerbäck S, Pelto-Huikko M. Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions. Dev Dyn 2000; 218: 136-49